Vanguard Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.39M Buy
56,631
+3,352
+6% +$358K ﹤0.01% 995
2026
Q2
$5.92M Buy
53,279
+3,590
+7% +$325K ﹤0.01% 964
2026
Q1
$4.32M Buy
+49,689
New +$4.83M ﹤0.01% 1019

Other funds holding RYTM

Vanguard Asset Management's RYTM Position: Q3 2026 in Review

Vanguard Asset Management increased its Rhythm Pharmaceuticals (RYTM) stake by 6.3% in Q3 2026, buying an estimated $358K and bringing the position to 56,631 shares worth $5.39M. The position accounts for ﹤0.01% of the portfolio, ranked #995.

Vanguard Asset Management first reported a position in RYTM in Q1 2026 and has held it in 3 quarters since. The position peaked at $5.92M in Q2 2026. 329 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.

  • Vanguard Asset Management held 56,631 shares of Rhythm Pharmaceuticals worth $5.39M as of Q3 2026.
  • Vanguard Asset Management bought 3,352 Rhythm Pharmaceuticals shares in Q3 2026, an estimated $358K.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #995 holding.
  • Vanguard Asset Management first reported a position in Rhythm Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Asset Management's Rhythm Pharmaceuticals position peaked at $5.92M in Q2 2026.
  • 329 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.